S&P 500   3,811.15 (-0.48%)
DOW   30,932.37 (-1.50%)
QQQ   314.14 (+0.42%)
AAPL   121.26 (+0.22%)
MSFT   232.38 (+1.48%)
FB   257.62 (+1.15%)
GOOGL   2,021.91 (+0.30%)
AMZN   3,092.93 (+1.17%)
TSLA   675.50 (-0.99%)
NVDA   548.58 (+3.06%)
BABA   237.76 (-1.01%)
CGC   32.75 (-1.39%)
GE   12.54 (-1.72%)
MU   91.53 (+3.87%)
NIO   45.78 (-2.20%)
AMD   84.51 (+2.54%)
T   27.89 (-2.58%)
F   11.70 (-0.51%)
ACB   10.52 (-2.77%)
DIS   189.04 (-1.02%)
BA   212.01 (-2.05%)
NFLX   538.85 (-1.44%)
BAC   34.71 (-3.40%)
S&P 500   3,811.15 (-0.48%)
DOW   30,932.37 (-1.50%)
QQQ   314.14 (+0.42%)
AAPL   121.26 (+0.22%)
MSFT   232.38 (+1.48%)
FB   257.62 (+1.15%)
GOOGL   2,021.91 (+0.30%)
AMZN   3,092.93 (+1.17%)
TSLA   675.50 (-0.99%)
NVDA   548.58 (+3.06%)
BABA   237.76 (-1.01%)
CGC   32.75 (-1.39%)
GE   12.54 (-1.72%)
MU   91.53 (+3.87%)
NIO   45.78 (-2.20%)
AMD   84.51 (+2.54%)
T   27.89 (-2.58%)
F   11.70 (-0.51%)
ACB   10.52 (-2.77%)
DIS   189.04 (-1.02%)
BA   212.01 (-2.05%)
NFLX   538.85 (-1.44%)
BAC   34.71 (-3.40%)
S&P 500   3,811.15 (-0.48%)
DOW   30,932.37 (-1.50%)
QQQ   314.14 (+0.42%)
AAPL   121.26 (+0.22%)
MSFT   232.38 (+1.48%)
FB   257.62 (+1.15%)
GOOGL   2,021.91 (+0.30%)
AMZN   3,092.93 (+1.17%)
TSLA   675.50 (-0.99%)
NVDA   548.58 (+3.06%)
BABA   237.76 (-1.01%)
CGC   32.75 (-1.39%)
GE   12.54 (-1.72%)
MU   91.53 (+3.87%)
NIO   45.78 (-2.20%)
AMD   84.51 (+2.54%)
T   27.89 (-2.58%)
F   11.70 (-0.51%)
ACB   10.52 (-2.77%)
DIS   189.04 (-1.02%)
BA   212.01 (-2.05%)
NFLX   538.85 (-1.44%)
BAC   34.71 (-3.40%)
S&P 500   3,811.15 (-0.48%)
DOW   30,932.37 (-1.50%)
QQQ   314.14 (+0.42%)
AAPL   121.26 (+0.22%)
MSFT   232.38 (+1.48%)
FB   257.62 (+1.15%)
GOOGL   2,021.91 (+0.30%)
AMZN   3,092.93 (+1.17%)
TSLA   675.50 (-0.99%)
NVDA   548.58 (+3.06%)
BABA   237.76 (-1.01%)
CGC   32.75 (-1.39%)
GE   12.54 (-1.72%)
MU   91.53 (+3.87%)
NIO   45.78 (-2.20%)
AMD   84.51 (+2.54%)
T   27.89 (-2.58%)
F   11.70 (-0.51%)
ACB   10.52 (-2.77%)
DIS   189.04 (-1.02%)
BA   212.01 (-2.05%)
NFLX   538.85 (-1.44%)
BAC   34.71 (-3.40%)
Log in
NASDAQ:MESO

Mesoblast Short Interest Ratio and Short Volume

$9.60
0.00 (0.00 %)
(As of 02/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$9.60
Now: $9.60
$9.60
50-Day Range
$8.66
MA: $9.79
$11.40
52-Week Range
$3.12
Now: $9.60
$21.28
VolumeN/A
Average Volume930,300 shs
Market Capitalization$1.13 billion
P/E RatioN/A
Dividend YieldN/A
Beta3.71

Short Interest

Mesoblast (NASDAQ:MESO) Short Interest Data

Current Short Volume3,140,000 shares
Previous Short Volume3,730,000 shares
Change Vs. Previous Month:-15.82%
Dollar Volume Sold Short$31.12 million
Short Interest Ratio / Days to Cover4.0
Last Record DateJanuary, 29 2021
Outstanding Shares99,730,000 shares
Percentage of Shares Shorted2.67%
Today's Trading Volume0 shares
Average Trading Volume930,300 shares
Today's Volume Vs. Average-100.00%

Short Interest Over Time


Mesoblast (NASDAQ:MESO) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/29/20213,140,000 shares $31.12 million -15.8%N/A4 $9.91
1/15/20213,730,000 shares $34.35 million +11.0%N/A4.8 $9.21
12/31/20203,110,000 shares $35.45 million -0.3%N/A5 $11.40
12/15/20203,110,000 shares $27.15 million -0.3%N/A5 $8.73
11/30/20203,120,000 shares $28.92 million -4.9%N/A5.7 $9.27
11/15/20203,280,000 shares $49.50 million +0.9%N/A5.2 $15.09
10/30/20203,250,000 shares $38.61 million +8.7%N/A3 $11.88
10/15/20202,990,000 shares $32.23 million -4.8%N/A2.5 $10.78
9/30/20203,140,000 shares $37.81 million +18.1%N/A2.7 $12.04
9/15/20202,660,000 shares $46.66 million +21.5%N/A2.5 $17.54
8/31/20202,190,000 shares $35.83 million +7.9%N/A2.1 $16.36
8/14/20202,030,000 shares $38.47 million +25.3%N/A2 $18.95
7/31/20201,620,000 shares $31.70 million +14.1%N/A2.9 $19.57
7/15/20201,420,000 shares $19.06 million +19.3%N/A1.3 $13.42
6/30/20201,190,000 shares $14.86 million +26.8%N/A1 $12.49
6/15/2020938,400 shares $10.79 million +11.9%N/A0.8 $11.50
5/29/2020838,700 shares $9.65 million -28.3%N/A0.7 $11.51
5/15/20201,170,000 shares $15.01 million +10.4%N/A1.1 $12.83
4/30/20201,060,000 shares $13.99 million +76.6%N/A1.1 $13.20
4/15/2020600,400 shares $6.84 million +158.6%N/A0.8 $11.39
3/31/2020232,200 shares $3.59 million +46.4%N/A1.2 $15.45
3/13/2020158,600 shares $1.10 million -16.1%N/A1 $6.96
2/28/2020189,000 shares $638,820.00 -41.0%N/A2.2 $3.38
2/14/2020320,500 shares $2.39 million +8.6%N/A4.4 $7.45
1/31/2020295,000 shares $2.43 million +7.8%N/A4.6 $8.24

Mesoblast (NASDAQ:MESO) Short Interest FAQ

speech bubbles
speech bubbles











What is Mesoblast's current short interest?

Short interest is the volume of Mesoblast shares that have been sold short but have not yet been closed out or covered. As of January 29th, investors have sold 3,140,000 shares of MESO short.

What is a good short interest ratio for Mesoblast?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Mesoblast currently has a short interest ratio of 4.0.

Is Mesoblast's short interest increasing or decreasing?

Mesoblast saw a decrease in short interest during the month of January. As of January 29th, there was short interest totaling 3,140,000 shares, a decrease of 15.8% from the previous total of 3,730,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Mesoblast's short interest compare to its competitors?

0.00% of Mesoblast's shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Mesoblast: SpringWorks Therapeutics, Inc. (9.26%), Relay Therapeutics, Inc. (12.09%), NantKwest, Inc. (18.76%), NanoString Technologies, Inc. (0.00%), Revolution Medicines, Inc. (8.21%), Editas Medicine, Inc. (0.00%), Sorrento Therapeutics, Inc. (0.00%), Bavarian Nordic A/S (0.00%), AlloVir, Inc. (7.90%), and Vericel Co. (0.00%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Aon Plc ($5.34 billion), Charter Communications, Inc. ($5.03 billion), ViacomCBS Inc. ($4.99 billion), DuPont de Nemours, Inc. ($4.72 billion), Analog Devices, Inc. ($4.57 billion), Snap Inc. ($3.87 billion), Moderna, Inc. ($3.58 billion), Futu Holdings Limited ($2.75 billion), Snowflake Inc. ($2.43 billion), and Palantir Technologies Inc. ($2.18 billion). View all of the most shorted stocks.

What does it mean to sell short Mesoblast stock?

Short selling MESO is an investing strategy that aims to generate trading profit from Mesoblast as its price is falling. To short Mesoblast stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Mesoblast will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Mesoblast?

A short squeeze for Mesoblast occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MESO, which in turn drives the price of the stock up even further.

How often is Mesoblast's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MESO, twice per month. The most recent reporting period available is January, 29 2021.



This page was last updated on 2/26/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.